The brain-derived neurotrophic factor val66met polymorphism and cerebral white matter hyperintensities in late-life depression

Warren D. Taylor, Stephan L Zuchner, Douglas R. McQuoid, Martha E. Payne, James R. MacFall, David C. Steffens, Marcy C. Speer, K. Ranga R Krishnan

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Objective: In animal models, brain-derived neurotrophic factor (BDNF) appears to protect against cerebral ischemia. The authors examined whether the BDNF Val66Met polymorphism, which affects BDNF distribution, was associated with greater volumes of hyperintense lesions as detected on magnetic resonance imaging in a cohort of depressed and nondepressed elders. Design: Subjects completed cross-sectional assessments, including clinical evaluation and a brain magnetic resonance imaging scan, and provided blood samples for Val66Met genotyping. Setting: The study was conducted at a university-based academic hospital. Participants: Participants included 199 depressed and 113 nondepressed subjects aged 60 years or older. Measurement: Hyperintensity lesion volumes were measured using a semiautomated segmentation procedure. Statistical models examined the relationship between genotype and lesion volume while controlling for depression, presence of hypertension, age, and sex. Results: After controlling for covariates, Met66 allele carriers exhibited significantly greater white matter hyperintensity volumes (F1,311 ≤ 4.09, p ≤ 0.0442). This effect was independent of a diagnosis of depression or report of hypertension. Genotype was not significantly related to gray matter hyperintensity volume (F1,311 ≤ 1.14, p ≤ 0.2871). Conclusions: The BDNF Met66 allele is associated with greater white matter hyperintensity volumes in older individuals. Further work is needed to determine how this may be associated with other clinically relevant findings in late-life depression.

Original languageEnglish
Pages (from-to)263-271
Number of pages9
JournalAmerican Journal of Geriatric Psychiatry
Volume16
Issue number4
DOIs
StatePublished - Apr 1 2008

Fingerprint

Brain-Derived Neurotrophic Factor
Alleles
Genotype
Magnetic Resonance Imaging
Hypertension
Statistical Models
Brain Ischemia
Animal Models
White Matter
Brain

Keywords

  • Depression
  • Genetic polymorphisms
  • Magnetic resonance imaging

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology
  • Medicine(all)

Cite this

The brain-derived neurotrophic factor val66met polymorphism and cerebral white matter hyperintensities in late-life depression. / Taylor, Warren D.; Zuchner, Stephan L; McQuoid, Douglas R.; Payne, Martha E.; MacFall, James R.; Steffens, David C.; Speer, Marcy C.; Krishnan, K. Ranga R.

In: American Journal of Geriatric Psychiatry, Vol. 16, No. 4, 01.04.2008, p. 263-271.

Research output: Contribution to journalArticle

Taylor, Warren D. ; Zuchner, Stephan L ; McQuoid, Douglas R. ; Payne, Martha E. ; MacFall, James R. ; Steffens, David C. ; Speer, Marcy C. ; Krishnan, K. Ranga R. / The brain-derived neurotrophic factor val66met polymorphism and cerebral white matter hyperintensities in late-life depression. In: American Journal of Geriatric Psychiatry. 2008 ; Vol. 16, No. 4. pp. 263-271.
@article{2d1dbf8523224c79b002750139eb46e7,
title = "The brain-derived neurotrophic factor val66met polymorphism and cerebral white matter hyperintensities in late-life depression",
abstract = "Objective: In animal models, brain-derived neurotrophic factor (BDNF) appears to protect against cerebral ischemia. The authors examined whether the BDNF Val66Met polymorphism, which affects BDNF distribution, was associated with greater volumes of hyperintense lesions as detected on magnetic resonance imaging in a cohort of depressed and nondepressed elders. Design: Subjects completed cross-sectional assessments, including clinical evaluation and a brain magnetic resonance imaging scan, and provided blood samples for Val66Met genotyping. Setting: The study was conducted at a university-based academic hospital. Participants: Participants included 199 depressed and 113 nondepressed subjects aged 60 years or older. Measurement: Hyperintensity lesion volumes were measured using a semiautomated segmentation procedure. Statistical models examined the relationship between genotype and lesion volume while controlling for depression, presence of hypertension, age, and sex. Results: After controlling for covariates, Met66 allele carriers exhibited significantly greater white matter hyperintensity volumes (F1,311 ≤ 4.09, p ≤ 0.0442). This effect was independent of a diagnosis of depression or report of hypertension. Genotype was not significantly related to gray matter hyperintensity volume (F1,311 ≤ 1.14, p ≤ 0.2871). Conclusions: The BDNF Met66 allele is associated with greater white matter hyperintensity volumes in older individuals. Further work is needed to determine how this may be associated with other clinically relevant findings in late-life depression.",
keywords = "Depression, Genetic polymorphisms, Magnetic resonance imaging",
author = "Taylor, {Warren D.} and Zuchner, {Stephan L} and McQuoid, {Douglas R.} and Payne, {Martha E.} and MacFall, {James R.} and Steffens, {David C.} and Speer, {Marcy C.} and Krishnan, {K. Ranga R}",
year = "2008",
month = "4",
day = "1",
doi = "10.1097/JGP.0b013e3181591c30",
language = "English",
volume = "16",
pages = "263--271",
journal = "American Journal of Geriatric Psychiatry",
issn = "1064-7481",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - The brain-derived neurotrophic factor val66met polymorphism and cerebral white matter hyperintensities in late-life depression

AU - Taylor, Warren D.

AU - Zuchner, Stephan L

AU - McQuoid, Douglas R.

AU - Payne, Martha E.

AU - MacFall, James R.

AU - Steffens, David C.

AU - Speer, Marcy C.

AU - Krishnan, K. Ranga R

PY - 2008/4/1

Y1 - 2008/4/1

N2 - Objective: In animal models, brain-derived neurotrophic factor (BDNF) appears to protect against cerebral ischemia. The authors examined whether the BDNF Val66Met polymorphism, which affects BDNF distribution, was associated with greater volumes of hyperintense lesions as detected on magnetic resonance imaging in a cohort of depressed and nondepressed elders. Design: Subjects completed cross-sectional assessments, including clinical evaluation and a brain magnetic resonance imaging scan, and provided blood samples for Val66Met genotyping. Setting: The study was conducted at a university-based academic hospital. Participants: Participants included 199 depressed and 113 nondepressed subjects aged 60 years or older. Measurement: Hyperintensity lesion volumes were measured using a semiautomated segmentation procedure. Statistical models examined the relationship between genotype and lesion volume while controlling for depression, presence of hypertension, age, and sex. Results: After controlling for covariates, Met66 allele carriers exhibited significantly greater white matter hyperintensity volumes (F1,311 ≤ 4.09, p ≤ 0.0442). This effect was independent of a diagnosis of depression or report of hypertension. Genotype was not significantly related to gray matter hyperintensity volume (F1,311 ≤ 1.14, p ≤ 0.2871). Conclusions: The BDNF Met66 allele is associated with greater white matter hyperintensity volumes in older individuals. Further work is needed to determine how this may be associated with other clinically relevant findings in late-life depression.

AB - Objective: In animal models, brain-derived neurotrophic factor (BDNF) appears to protect against cerebral ischemia. The authors examined whether the BDNF Val66Met polymorphism, which affects BDNF distribution, was associated with greater volumes of hyperintense lesions as detected on magnetic resonance imaging in a cohort of depressed and nondepressed elders. Design: Subjects completed cross-sectional assessments, including clinical evaluation and a brain magnetic resonance imaging scan, and provided blood samples for Val66Met genotyping. Setting: The study was conducted at a university-based academic hospital. Participants: Participants included 199 depressed and 113 nondepressed subjects aged 60 years or older. Measurement: Hyperintensity lesion volumes were measured using a semiautomated segmentation procedure. Statistical models examined the relationship between genotype and lesion volume while controlling for depression, presence of hypertension, age, and sex. Results: After controlling for covariates, Met66 allele carriers exhibited significantly greater white matter hyperintensity volumes (F1,311 ≤ 4.09, p ≤ 0.0442). This effect was independent of a diagnosis of depression or report of hypertension. Genotype was not significantly related to gray matter hyperintensity volume (F1,311 ≤ 1.14, p ≤ 0.2871). Conclusions: The BDNF Met66 allele is associated with greater white matter hyperintensity volumes in older individuals. Further work is needed to determine how this may be associated with other clinically relevant findings in late-life depression.

KW - Depression

KW - Genetic polymorphisms

KW - Magnetic resonance imaging

UR - http://www.scopus.com/inward/record.url?scp=48649102220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48649102220&partnerID=8YFLogxK

U2 - 10.1097/JGP.0b013e3181591c30

DO - 10.1097/JGP.0b013e3181591c30

M3 - Article

C2 - 18263664

AN - SCOPUS:48649102220

VL - 16

SP - 263

EP - 271

JO - American Journal of Geriatric Psychiatry

JF - American Journal of Geriatric Psychiatry

SN - 1064-7481

IS - 4

ER -